50 employees
Sequel Pharmaceuticals develops and commercializes novel and clinical-stage drug candidates for patients with cardiovascular disease.
2007
$20M
from 5 investors over 5 rounds
Sequel Pharmaceuticals, Inc. raised $20M on September 27, 2007
Investors: Montreux Equity Partners, Domain Associates, Forward Ventures, InterWest Partners and Sky Ventures